Drug Trial Radar · NCT01104792
Long-term Study of Cariprazine in Patients With Schizophrenia
Last checked: Nov 20, 2026Latest source record: Jul 26, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
752
Actual
Start
May 31, 2010
Primary completion
Jan 31, 2013
Study completion Jan 31, 2013
Sponsor
- Lead sponsor
- Forest LaboratoriesAbbVie (ABBV)
- Sponsor type
- Industry
- Collaborators
- Gedeon Richter Ltd.
- First posted
- Apr 15, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.
Conditions
- Schizophrenia
Interventions
CariprazineDrug
Cariprazine was supplied in capsules.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 48 in the PANSS Total ScoreTime frame: Baseline to Week 48
Locations
86 sites in 6 countries. Site status is shown where the registry gives one.
Forest Investigative Site 072
Little Rock, Arkansas
Forest Investigative Site 021
Little Rock, Arkansas
Forest Investigative Site 086
Little Rock, Arkansas
Forest Investigative Site 014
Springdale, Arkansas
Forest Investigative Site 080
Carson, California
Forest Investigative Site 079
Cerritos, California
Forest Investigative Site 048
Costa Mesa, California
Forest Investigative Site 070
Costa Mesa, California
Forest Investigative Site 022
Garden Grove, California
Forest Investigative Site 083
Garden Grove, California
Forest Investigative Site 050
Long Beach, California
Forest Investigative Site 006
Oceanside, California
Forest Investigative Site 003
Riverside, California
Forest Investigative Site 016
San Diego, California
Forest Investigative Site 073
Santa Ana, California
Forest Investigative Site 071
New Britain, Connecticut
Forest Investigative Site 002
Bradenton, Florida
Forest Investigative Site 041
Kissimmee, Florida
Forest Investigative Site 082
North Miami, Florida
Forest Investigative Site 055
Atlanta, Georgia
Forest Investigative Site 087
Atlanta, Georgia
Forest Investigative Site 012
Honolulu, Hawaii
Forest Investigative Site 018
Chicago, Illinois
Forest Investigative Site 008
Hoffman Estates, Illinois
Forest Investigative Site 044
Rockville, Maryland
Forest Investigative Site 007
Flowood, Mississippi
Forest Investigative Site 017
Creve Coeur, Missouri
Forest Investigative Site 076
Saint Charles, Missouri
Forest Investigative Site 045
St Louis, Missouri
Forest Investigative Site 052
Las Vegas, Nevada
Forest Investigative Site 004
Willingboro, New Jersey
Forest Investigative Site 040
Cedarhurst, New York
Forest Investigative Site 019
Willoughby, Ohio
Forest Investigative Site 077
Philadelphia, Pennsylvania
Forest Investigative Site 047
Philadelphia, Pennsylvania
Forest Investigative Site 074
Austin, Texas
Forest Investigative Site 084
DeSoto, Texas
Forest Investigative Site 043
Irving, Texas
Forest Investigative Site 078
Bellevue, Washington
Forest Investigative Site 602
Bogotá, Colombia
Showing 40 of 86 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.